The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat
2/5 14:45
Earnings season is in full swing, and on April 29, three Big Pharma mainstays reported Q1 2026 earnings. Investors were looking for strong results—and strong guidance—that could serve as a sorely needed tailwind for the healthcare sector. So far in 2026, that corner of the marke...